| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |